Pulsed electric fields for cardiac ablation and beyond: A state-of-the-art review.

Ablation Electroporation Irreversible electroporation Pulsed electric fields Radiofrequency

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
07 2019
Historique:
received: 11 11 2018
pubmed: 15 1 2019
medline: 4 11 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Irreversible electroporation (IRE) occurs when a strong, pulsed electric field (PEF) causes permeabilization of the cell membrane, leading to cellular homeostasis disruption and cell death. IRE is a Food and Drug Administration-approved treatment of tumor ablation and has been gaining attention in cardiology as an ablation modality. Applications of PEF in cardiology are vast and include atrial fibrillation, ventricular fibrillation, septal ablation, and targeting vascular structures. PEF has appealing characteristics, including the ability to be tissue specific and its nonthermal nature. This review provides information on the biophysics and mechanisms of IRE, summarizes key studies and applications to date, and provides insight into future applications.

Identifiants

pubmed: 30641148
pii: S1547-5271(19)30012-8
doi: 10.1016/j.hrthm.2019.01.012
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1112-1120

Informations de copyright

Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Elad Maor (E)

Leviev Heart Center, Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Alan Sugrue (A)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Chance Witt (C)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Vaibhav R Vaidya (VR)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Christopher V DeSimone (CV)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Samuel J Asirvatham (SJ)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.

Suraj Kapa (S)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: kapa.suraj@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH